Anton Leshchenko

CGM CEE Rare Disease Business Unit

Emerging markets of Africa (MAGREB, SADEC, FWA), Russia/CIS and MENA Life Science, Biotech, Medical Disposables, Veterinary, Digital Medicine - M&A Buy-Side / Acquisition - M&A Sell-Side / Divestment - In Licensing - Out Licensing - Market entrance consultancy - Tailored customer based Projects

Strategic and Operations Development • Board member role responsible for the Gap analysis and Global expansion of SOTHEMA • Extending plan to SADEC, Eastern and Central Europe, GCC/MENA, Asia • Strategic and Alliance Partnerships with Global Pharma leaders for In-, Out- license and contract manufacturing services. Global BD&L

• Market entrance to Russia/CIS • Entrance for manufacturers from Russia/CIS to Africa, MENA, LATCAM • Spearhead partnership projects in base and niche medical disposables and pharmaceuticals in Russia/CIS (Common Independent States) • Distribution network and coordinate high-impact promotions for private and tender business to cover all Russia, Belarus, Kazakhstan • Access and reimbursement Board Member

• Launched holding structure from scratch to expand Avacare Group into international/global business operations in core lines such as Medical Disposables, Pharmaceuticals, and Orthopedics. • Instituted fully-fledged affiliates in CIS, Russia, and subsequently in Eastern Europe (e.g. Ukraine, Georgia, Uzbekistan). • Successfully forged partnerships in Russia, Kazakhstan, Belarus, Azerbaijan, Moldova, and Armenia.

• Distribution strategy for 24 markets in LATAM and CARICAM within 2 years. • Relationships with key distributors and affiliates’ commercial heads, as well as two partner companies, Iroko Holdings and Coreveo. • Board member for both Aspen and two partner companies. • Championed full-scope project management for Iroko deal encompassing more than 46 countries. • Solicited, negotiated, and secured distribution contract with 12 distributors globally, and propelled sales in key markets by 12%+ annually.

Corporate Talent Development Program 2008 • Developed, mentored, motivated, and empowered team of eight medical representatives and affiliate portfolio comprising Endo, CNS, Oncology and Retail (Cialis) products • Controlled and expanded region representing 28% of territory in Russia • Reversed declining sales trend to boost cumulative growth by 8% over 12 months • Successfully positioned Cialis and retail team

• Aligned, mobilized, and directed four marketers, led co-marketing activities with Boheringer Ingelheim, in Psychiatry and Neurology of Russia. • Advocacy group support strategy and held Six Sigma Green Belt consulting • Launched products in Russia and CIS • Shepherded anti-crisis Federal Reimbursement List in Russia. • Fueled sales in private and other non-reimbursed channels

• Provided influential marketing leadership for new pharmaceuticals from discovery through product decision and preparation for commercial success. • Planned, coordinated, and effectively orchestrated launch of new antidepressant (Cymbalta) in Russia. • Forged partnership with Boehringer Ingelheim to promote Duloxetine in Russia/CIS and set up NPP (New Product Planning) process with Russian affiliate and CIS.

• Helmed P&L analysis and optimization by supervising complete spectrum of financial functions spanning budgeting, forecasting, business planning, financial metrics analysis, EVA, corporate finance affiliate metrics analysis, and risk management. • Implemented cross-functional process for business planning cycle which improved efficiency and quality of regional submissions.

Marketing, Finance

Marketing